Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects

NCT02016560 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: florbetapir F 18
DRUG: Flortaucipir F18
PROCEDURE: Brain PET Scan

Sponsor

Avid Radiopharmaceuticals